Enzymatic Therapy, LLCDownload PDFTrademark Trial and Appeal BoardSep 8, 2016No. 86186571 (T.T.A.B. Sep. 8, 2016) Copy Citation This Opinion is not a Precedent of the TTAB Mailed: September 8, 2016 UNITED STATES PATENT AND TRADEMARK OFFICE _____ Trademark Trial and Appeal Board _____ In re Enzymatic Therapy, LLC _____ Serial No. 86186571 _____ Aaron J. Wong of Price Heneveld LLP, for Enzymatic Therapy, LLC. Alison F. Pollack, Trademark Examining Attorney, Law Office 106, Mary I. Sparrow, Managing Attorney. _____ Before Kuhlke, Mermelstein, and Shaw, Administrative Trademark Judges. Opinion by Shaw, Administrative Trademark Judge: Enzymatic Therapy, LLC (“Applicant”) seeks registration on the Principal Register of the mark Serial No. 86186571 - 2 - for “dietary and nutritional supplements,” in International Class 5.1 The description of the mark reads: “The mark consists of the wording ‘ENZYMATIC THERAPY’ with a y-shaped stylized human figure with arms upraised representing the first letter ‘Y’ in ‘ENZYMATIC THERAPY.’” Applicant has disclaimed the word THERAPY and claims the words “ENZYMATIC THERAPY” have acquired distinctiveness under Section 2(f) based on more than 5 years of substantially exclusive and continuous use in commerce. Applicant also claims ownership of the following three prior registrations: • Reg. No. 1760946, for the typed mark ENZYMATIC THERAPY (registered under Section 2(f) with a disclaimer of ENZYMATIC), issued on March 30, 1993, claiming a date of first use in commerce of February 11, 1981, for “dietary food supplements,” in International Class 5 (renewed); • Reg. No. 3171940, for the mark (with a disclaimer of THERAPY), issued on November 14, 2006, claiming a date of first use in commerce of April 5, 2005, for “Dietary and Nutritional Supplements,” in International Class 5 (Section 8 affidavit accepted); and • Reg. No. 3171941, for the mark (with a disclaimer of THERAPY), issued on November 14, 2006, claiming a date of first use in commerce of May 1, 2005, for “Dietary and Nutritional Supplements,” in International Class 5 (Section 8 affidavit accepted). The Trademark Examining Attorney refused registration of Applicant’s mark under Section 2(a) of the Trademark Act, 15 U.S.C. § 1052(a), on the ground that Applicant’s mark is deceptive. When the refusal was made final, Applicant appealed. The case is fully briefed. 1 Application Serial No. 86186571 was filed on February 6, 2014, based upon Applicant’s allegation of a bona fide intention to use the mark in commerce under Section 1(b) of the Trademark Act, 15 U.S.C. § 1(b). Serial No. 86186571 - 3 - Analysis In accordance with Section 2(a) of the Trademark Act, registration must be refused if a mark is deceptive of a feature or an ingredient of the identified goods. In re Budge, 857 F.2d 773, 8 USPQ2d 1259, 1260 (Fed. Cir. 1988). The test for deceptiveness is whether all three of the following criteria are met: (1) The applied-for mark consists of or contains a term that misdescribes the character, quality, function, composition, or use of the goods and/or services; (2) Prospective purchasers are likely to believe that the misdescription actually describes the goods and/or services; and (3) The misdescription is likely to affect a significant portion of the relevant consumers’ decision to purchase the goods and/or services. In re Budge, 8 USPQ2d at 1260. Moreover, because Section 2(a) is an absolute bar to the registration of deceptive matter on either the Principal Register or the Supplemental Register, a claim that a mark has acquired distinctiveness cannot obviate a Section 2(a) deceptiveness refusal. See In re Charles S. Loeb Pipes, Inc., 190 USPQ 238, 241 (TTAB 1975); TMEP § 1203.02 (Apr. 2016). However, evidence of use and of recognition by consumers and the trade can be considered in analyzing the first and second factors of the Budge test; that is, such evidence may be considered in determining whether the mark misdescribes the goods and whether prospective purchasers are likely to believe that the misdescription actually describes the goods. In re Woolrich Woolen Mills Inc., 13 USPQ2d 1235 (1989) (holding WOOLRICH for clothing not made of wool found not to be deceptive under Section 2(a), due to consumer and trade recognition of WOOLRICH as a trademark as a result of applicant’s long and extensive use). Serial No. 86186571 - 4 - Regarding the first Budge factor, it is the Examining Attorney’s position that “Applicant’s mark includes the wording ‘ENZYMATIC,’ indicating that the goods have or exhibit the following feature or characteristic: enzymes” whereas, as Applicant admits, some of Applicant’s goods do not contain enzymes. Thus, the Examining Attorney continues, “the term ‘ENZYMATIC’ misdescribes a character, quality, and composition of the goods, namely, that the goods contain enzymes.”2 According to definitions introduced by the Examining Attorney, an “enzyme” is defined as: A substance produced by a living organism that acts as a catalyst to bring about a specific biochemical reaction. Most enzymes are proteins with large complex molecules whose action depends on their particular molecular shape. Some enzymes control reactions within cells and some, such as the enzymes involved in digestion, outside them.3 The adjective form of enzyme, “enzymatic,” is defined as “of, relating to, or produced by an enzyme.”4 The Examining Attorney introduced a number of articles explaining the role enzymes play in digestion. For example, the article on the website WebMD explains that the human pancreas releases “digestive enzymes, which are natural substances needed by the body to break down and digest food.”5 Many of the articles encourage enzyme supplements as an aid in digestion, claiming that the pancreas can “slow 2 Examining Attorney’s Br., pp. 7-8. 3 Oxforddictionaries.com, Office Action of September 8, 2015, pp. 2-4. 4 Merriam-webster.com, Office Action of September 8, 2015, pp. 5-8. 5 Office Action of February 26, 2015, p. 64. Serial No. 86186571 - 5 - down as we age,”6 and that factors such as “stress, poor sleep, illness, antibiotic use, smoking, alcohol abuse, and a diet rich in hard-to-digest processed, refined, and fatty foods” can deplete the “supply of natural enzymes.”7 Enzyme supplements are encouraged as a way to enhance digestion by providing enzymes “when the pancreas cannot make or does not release enough digestive enzymes into the gut to digest the food.”8 These web articles state that digestive enzymes include lactase for digesting dairy products, alpha-galactosidase for digesting beans, proteases for digesting proteins, amylase for digesting starches, and lipase for digesting fats.9 Moreover, at least one website provided by the Examining Attorney claims that “probiotics” are a type of microorganism that provide digestion benefits similar to those of enzyme supplements: “Probiotics produce enzymes such as protease, lipase, and lactase to further assist with protein and fat digestion as well as reduce problems associated with lactose intolerance.”10 The Examining Attorney introduced excerpts from websites selling a number of nutritional supplement products containing enzymes for use in supporting the 6 Office Action of February 26, 2015, p. 60. 7 Office Action of September 8, 2015, p. 56. 8 Office Action of February 26, 2015, p. 64. 9 Office Action of February 26, 2015, p. 61. 10 Enzymeessentials.com, Office Action of September 8, 2015, p. 80-86. We make no ruling on the veracity of statements involving the efficacy of these supplements inasmuch as nearly all of these website articles point out that such “[s]tatements have not been evaluated by the Food and Drug Administration. Products not intended to diagnose, treat, cure, or prevent any disease.” Id. Nevertheless, the websites do show how nutritional supplements are marketed to prospective consumers and, therefore, what ingredients consumers might expect to find in the products. Serial No. 86186571 - 6 - digestive process. The amazon.com, vitaminshoppe.com, gnc.com, and walmart.com websites list enzyme-containing supplements which claim to aid in digestion. The supplements appear to contain individual enzymes or combinations of multiple enzymes, depending on the customer’s perceived need, e.g., lactose intolerance, gas from beans, gluten sensitivity, etc. Notably, however, these pages also list products claiming to aid digestion which either contain probiotics or which do not appear to contain enzymes. For example, the amazon.com website lists probiotic products alongside enzyme supplements on its “Health & Personal Care : Vitamins & Dietary Supplements : Supplements : Enzymes” page.11 Similarly, the vitaminshoppe.com website lists “probiotic” capsules, “peppermint oil,” “charcoal,” a pH “Booster Kit,” “mastic gum,” “tropical papaya,” and “herbal bitters” alongside enzyme supplements in its “Digestion & Super Foods/Enzymes” product category.12 The walmart.com website lists “probiotic” capsules, “magnesium citrate,” “multivitamins,” and “milk thistle extract” alongside enzyme supplements in its “Health-Vitamins-Supplements- Enzymes” product category.13 Applicant admits that the supplements sold under the mark include “supplements that contain enzymes, as well as supplements that do not contain enzymes.”14 Inasmuch as the mark is used on a wide variety of supplements, Applicant argues, inter alia, that 11 Office Action of February 26, 2015, pp. 30-34. 12 Office Action of February 26, 2015, pp. 35-56. 13 Office Action of September 8, 2015, pp. 50-54. 14 Applicant’s Br., p. 8. Serial No. 86186571 - 7 - The word “enzymatic” suggests a biological, kinetic, and therapeutic effect of Applicant’s product, and provides for an overall commercial impression that speaks to the consumer of a nutritional or health benefit. . . . This benefit could also be in the form of enzyme‐free ingredients which aid in natural processes of the consumer that are regulated by naturally occurring enzymes.15 Applicant, citing Woolrich, also argues that “the developed trademark significance demonstrated in the decades of use of Applicant’s [prior] registrations provides for sufficient trademark significance to replace any descriptive or misdescriptive significance that the term may have had when first adopted by Applicant.”16 Taken as a whole, the evidence of record shows several possible meanings of the term ENZYMATIC when used in connection with dietary and nutritional supplements. Although the Examining Attorney has shown that many nutritional supplements do, in fact, contain enzymes, the record also shows that some products, such as probiotics, do not contain enzymes but claim to produce enzymes to assist with digestion. In addition, other products, such as the above-mentioned “peppermint oil,” “charcoal,” “herbal bitters” “magnesium citrate,” “multivitamins,” etc., are sold online under the category “enzymes” alongside enzyme supplements but do not appear to contain enzymes. No explanation for this is given, but it may be that these products aid enzyme-related processes or aid the body in increasing its own natural production of enzymes. These uses of “enzyme” in connection with differing supplement products suggest various meanings which are consistent with the 15 Applicant’s Br., p. 9. 16 Id. at 12. Serial No. 86186571 - 8 - definition of ENZYMATIC, which includes merely “relating to . . . or produced by an enzyme.”17 Thus, we find it likely that Applicant’s prospective customers would view ENZYMATIC THERAPY supplements as not necessarily containing enzymes, but possibly containing ingredients which aid enzyme-related processes or otherwise assist the body in producing its own enzymes. Indeed, Applicant’s prior registrations for ENZYMATIC THERAPY marks for nutritional supplements not containing enzymes, suggest that consumers understand that Applicant’s supplements may not contain enzymes. See Woolrich, 13 USPQ2d at 1238 (“[A]ny descriptive or misdescriptive significance that the term may have had when first adopted has been largely replaced by trademark significance as a result of applicant's long and extensive use.”). We find that there is not sufficient evidence to establish that use of ENZYMATIC means that dietary and nutritional supplements must contain enzymes. Accordingly, the term ENZYMATIC does not misdescribe the character, quality, function, composition, or use of the goods, and, therefore, Applicant’s mark is not deceptive when used in connection with the identified goods. Decision: The refusal to register Applicant’s mark under Section 2(a) of the Lanham Act is reversed. 17 Merriam-webster.com, Office Action of September 8, 2015, pp. 5-8. Copy with citationCopy as parenthetical citation